PDB_ID,Title,Protein_description,NChain,Chain_ID,Num_Res,Complex,Discarted_Ligands,Branched,Branched_name,Branched_type,Branched_functions,Branched_Covalent,Branched_Bond,Ligand,Ligand_names,Ligand_types,Ligand_functions,Covalent_Bond,Bond,Mutation,Mutation_Location,Identity,Gaps
7TQ5,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 10d,3C-like proteinase,2,"A,B",309,Yes,"CL
PG4",,,,,,,"IRW
ITX","(1S,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 B
CYS145 B",0,[],98.39,5
7LKE,X-ray crystal structure of the SARS-CoV-2 main protease in space group C2,3C-like proteinase,1,A,306,No,,,,,,,,,,,,,,0,[],100.00,0
5RF1,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with NCL-00023830,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,T5G,4-bromobenzene-1-sulfonamide,non-polymer,,No,,0,[],100.00,0
7BAK,Crystal structure of SARS-CoV-2 main protease treated with ebselen,Main Protease,1,A,306,No,SE,,,,,,,,,,,,,0,[],100.00,0
5RE4,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1129283193,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,SZY,N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,0,[],100.00,0
6XHU,Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design,3C-like proteinase,2,"A,B",306,No,,,,,,,,,,,,,,0,[],100.00,0
5R7Y,PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z45617795,3C-like proteinase,1,A,306,Yes,"DMS
CL",,,,,,,JFM,N-(2-phenylethyl)methanesulfonamide,non-polymer,,No,,0,[],100.00,0
8GXH,The crystal structure of SARS-CoV-2 main protease in complex with 14b,3C-like proteinase nsp5,1,A,306,Yes,,,,,,,,0AX,"N-[(2S)-3-cyclohexyl-1-oxidanylidene-1-[[(2S,3R)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide",non-polymer,,Yes,CYS145 A,0,[],100.00,0
5REB,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2856434899,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,T0Y,1-[(thiophen-3-yl)methyl]piperidin-4-ol,non-polymer,,No,,0,[],100.00,0
5REK,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102327,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,T1Y,1-{4-[(3-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,0,[],100.00,0
6YNQ,Structure of SARS-CoV-2 Main Protease bound to 2-Methyl-1-tetralone.,3C-like proteinase,1,A,306,Yes,"DMS
CL",,,,,,,P6N,"(2~{S})-2-methyl-3,4-dihydro-2~{H}-naphthalen-1-one",non-polymer,,Yes,CYS145 A,0,[],100.00,0
5RGI,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z369936976 (Mpro-x0397),3C-like proteinase,1,A,306,Yes,DMS,,,,,,,U0P,"N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea",non-polymer,,No,,0,[],100.00,0
7AEG,"SARS-CoV-2 main protease in a covalent complex with SDZ 224015 derivative, compound 5",3C-like proteinase,1,A,305,Yes,DMS,,,,,,,PRD_000338,N-[(benzyloxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide,Peptide-like,Inhibitor,Yes,CYS145 A,0,[],99.67,1
7Z4S,Crystal structure of SARS-CoV-2 Mpro in complex with cyclic peptide GM4 including unnatural amino acids.,3C-like proteinase nsp5,2,"A,B",306,Yes,"PEG
DMS
EDO
PGE",,,,,,,(ACE)(DTY)FH(II7)LNLGYRPGC(NH2),Macrocyclic peptide inhibitor,polypeptide(L),,No,,0,[],100.00,0
7A1U,Structure of SARS-CoV-2 Main Protease bound to Fusidic Acid.,3C-like proteinase,1,A,306,Yes,"DMS
IMD",,,,,,,FUA,FUSIDIC ACID,non-polymer,,No,,0,[],100.00,0
6W63,Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77,3C-like proteinase,1,A,306,Yes,,,,,,,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,0,[],100.00,0
7JR4,SARS-CoV-2 3CL protease with alternative conformation of the active site promoted by methylene-bridged cysteine and lysine residues,3C-like proteinase,1,A,306,No,DMS,,,,,,,,,,,,,0,[],100.00,0
8DDL,SARS-CoV-2 Main Protease (Mpro) H163A Mutant Apo Structure,"ORF1a polyprotein
ORF1a polyprotein",2,"A,B","306, 306",No,"PGE
NA
PEG
EDO",,,,,,,,,,,,,"1
1","['H163A']
['H163A']","99.67
99.67","0
0"
7WQ9,Crystal structure of SARS-CoV-2 main protease in complex with Z-IETD-FMK,3C-like proteinase,1,A,307,Yes,,,,,,,,(P6S)I(GME)T(FL6)(CF0),Z-IETD-FMK,polypeptide(L),,Yes,CYS145 A,0,[],99.67,1
7P51,CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE COMPLEXED WITH FRAGMENT F01,3C-like proteinase,1,A,306,Yes,"NA
DMS",,,,,,,5P9,"N-(5-chloropyridin-2-yl)-3-oxo-2,3-dihydro-1H-indene-1-carboxamide",non-polymer,,No,,0,[],100.00,0
6LU7,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,3C-like proteinase,1,A,306,Yes,,,,,,,,PRD_002214,"N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE",Peptide-like,Inhibitor,Yes,CYS145 A,0,[],100.00,0
8DRW,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp9-nsp10 (C9) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp9-nsp10 (C9) cut site,14,"A,B,C,D,E,F,G,H,I,J,K,L,M,N",306,No,"NA
1PE
PEG
PO4",,,,,,,,,,,,,5,"['C145A', 'S301A', 'G302T', 'T304R', 'F305L']",98.37,0
7WQ8,Crystal structure of SARS-CoV-2 main protease in complex with Z-DEVD-FMK,3C-like proteinase,1,A,307,Yes,,,,,,,,(P6S)(FL6)(GME)V(FL6)(CF0),Z-DEVD-FMK,polypeptide(L),,Yes,CYS145 A,0,[],99.67,1
7NIJ,SARS-CoV-2 main protease (Mpro) in a novel conformational state.,3C-like proteinase nsp5,1,A,306,No,,,,,,,,,,,,,,0,[],100.00,0
5RF2,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1741969146,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,HVB,1-azanylpropylideneazanium,non-polymer,,No,,0,[],100.00,0
7ANS,Structure of SARS-CoV-2 Main Protease bound to Adrafinil.,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,RNW,2-[(diphenylmethyl)-oxidanyl-$l^{3}-sulfanyl]-~{N}-oxidanyl-ethanamide,non-polymer,,No,,0,[],100.00,0
8DRY,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp12-nsp13 (C12) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp12-nsp13 (C12) cut site,12,"A,B,C,D,E,F,G,H,I,J,K,L",306,No,PEG,,,,,,,,,,,,,6,"['C145A', 'S301P', 'G302H', 'V303T', 'T304V', 'F305L']",98.04,0
5REL,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102340,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,T2G,1-{4-[(3-methylphenyl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,0,[],100.00,0
6XB0,Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is highly reactive: Insights for enzyme mechanism and drug design,3C-like proteinase,1,A,306,No,DMS,,,,,,,,,,,,,0,[],100.00,0
7AQE,Structure of SARS-CoV-2 Main Protease bound to UNC-2327,3C-like proteinase,1,A,306,Yes,"CL
DMS",,,,,,,RV5,"N-1,2,3-Benzothiadiazol-6-yl-N'-[2-oxo-2-(1-piperidinyl)ethyl]urea also called unc-2327",non-polymer,,No,,0,[],100.00,0
8DRV,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp8-nsp9 (C8) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp8-nsp9 (C8) cut site,4,"A,B,C,D",306,No,1PE,,,,,,,,,,,,,4,"['C145A', 'G302A', 'T304K', 'F305L']",98.69,0
5R8T,"PanDDA analysis group deposition of ground-state model of SARS-CoV-2 main protease screened against DSI poised (Enamine), Fraglites and Peplites (Newcastle university), Mini Frags (Astex), York 3D (York university), electrophile cysteine covalent (Weizman institute) fragment libraries",3C-like proteinase,1,A,306,No,DMS,,,,,,,,,,,,,0,[],100.00,0
7B83,Structure of SARS-CoV-2 Main Protease bound to pyrithione zinc,3C-like proteinase,1,A,306,Yes,"IMD
DMS
CL",,,,,,,PK8,"9-oxa-7-thia-1-azonia-8$l^{2}-zincabicyclo[4.3.0]nona-1,3,5-triene",non-polymer,,No,,1,['N72L'],99.67,0
7AP6,Structure of SARS-CoV-2 Main Protease bound to MUT056399.,3C-like proteinase,1,A,306,Yes,,,,,,,,RQN,4-(4-ethyl-5-fluoranyl-2-oxidanyl-phenoxy)-3-fluoranyl-benzamide,non-polymer,,No,,0,[],100.00,0
7BAJ,Crystal structure of ligand-free SARS-CoV-2 main protease,Main Protease,1,A,306,No,,,,,,,,,,,,,,0,[],100.00,0
6XA4,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW241,3C-like proteinase,1,A,308,Yes,GOL,,,,,,,PRD_002391,inhibitor UAW241,Oligopeptide,Inhibitor,Yes,CYS145 A,0,[],99.35,2
6M2N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,3C-like proteinase,4,"A,B,C,D",306,Yes,,,,,,,,3WL,"5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one",non-polymer,,No,,0,[],100.00,0
5REJ,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102241,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,T1V,1-{4-[(thiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,0,[],100.00,0
8DRS,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp6-nsp7 (C6) cut site sequence,3C-like proteinase nsp5,3,"A,B,C",306,No,,,,,,,,,,,,,,5,"['C145A', 'S301K', 'G302V', 'V303A', 'F305V']",98.37,0
8DRT,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp6-nsp7 (C6) cut site sequence (form 2),3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,,,,,,,5,"['C145A', 'S301K', 'G302V', 'V303A', 'F305V']",98.37,0
8DRX,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp10-nsp11 (C10) cut site sequence (form 2),Fusion protein of 3C-like proteinase nsp5 and nsp10-nsp11 (C10) cut site,2,"A,B",306,No,NA,,,,,,,,,,,,,6,"['C145A', 'S301R', 'G302E', 'V303P', 'T304M', 'F305L']",98.04,0
8GVY,SARS CoV-2 Mpro in complex with D-3-149,3C-like proteinase nsp5,1,A,306,Yes,,,,,,,,(ACY)AI(0A9),"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE",polypeptide(L),,Yes,CYS145 A,0,[],100.00,0
5RG1,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with NCL-00024905,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,T9J,Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide,non-polymer,,No,,0,[],100.00,0
7RNW,SARS-CoV-2 Main Protease in complex with a cyclic peptide inhibitor,3C-like proteinase,4,"A,B,C,D",306,Yes,,,,,,,,(ACE)(DTY)LQYAVLRHKRRE(9OW),ACE-DTY-LEU-GLN-TYR-ALA-VAL-LEU-ARG-HIS-LYS-ARG-ARG-GLU-SEC,polypeptide(L),,No,,0,[],100.00,0
8DRR,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp4-nsp5 (C4) cut site sequence,3C-like proteinase nsp5,3,"A,B,C",306,No,NA,,,,,,,,,,,,,3,"['C145A', 'G302A', 'F305L']",98.37,2
5R80,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z18197050,3C-like proteinase,1,A,306,Yes,DMS,,,,,,,RZG,methyl 4-sulfamoylbenzoate,non-polymer,,No,,0,[],100.00,0
7VVT,SARS-CoV-2 3CL protease (3CLpro) in complex with a covalent inhibitor,3C-like proteinase,2,"A,B",306,Yes,,,,,,,,80X,N-(3-chlorophenyl)-2-[(2R)-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanamide,non-polymer,,No,,0,[],100.00,0
7BAL,Crystal structure of SARS-CoV-2 main protease treated with ebselen derivative of MR6-31-2,Main Protease,1,A,306,No,SE,,,,,,,,,,,,,0,[],100.00,0
7L14,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 26,3C-like proteinase,2,"A,B",306,Yes,,,,,,,,XFD,"2-{3-[3-chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile",non-polymer,,No,,0,[],100.00,0
8DRU,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp7-nsp8 (C7) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp7-nsp8 (C7) cut site,7,"A,B,C,D,E,F,G",306,No,"PO4
PEG
1PE",,,,,,,,,,,,,5,"['C145A', 'S301N', 'G302R', 'V303A', 'F305L']",98.37,0
